Cargando…

Radiotherapeutic treatment options for oligotopic malignant liver lesions

BACKGROUND: Several radiotherapeutic approaches for patients with oligotopic malignant liver lesions unfit for surgical resection exist. The most advanced competitive techniques are high-dose-rate (HDR) brachytherapy, Cyberknife, volume-modulated-arc therapy (VMAT) and Tomotherapy. We evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wust, Peter, Beck, Marcus, Dabrowski, Robert, Neumann, Oliver, Zschaeck, Sebastian, Kaul, David, Modest, Dominik P., Stromberger, Carmen, Gebauer, Bernhard, Ghadjar, Pirus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970808/ https://www.ncbi.nlm.nih.gov/pubmed/33726751 http://dx.doi.org/10.1186/s13014-021-01779-5

Ejemplares similares

Intermediate-term outcome after PSMA-PET guided high-dose radiotherapy of recurrent high-risk prostate cancer patients
por: Zschaeck, Sebastian, et al.
Publicado: (2017)

PET measured hypoxia and MRI parameters in re-irradiated head and neck squamous cell carcinomas: findings of a prospective pilot study
por: Rogasch, Julian, et al.
Publicado: (2021)

Non-thermal effects of radiofrequency electromagnetic fields
por: Wust, Peter, et al.
Publicado: (2020)

Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)
por: Beck, Marcus, et al.
Publicado: (2021)

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients
por: Zschaeck, Sebastian, et al.
Publicado: (2017)

Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma
por: Zschaeck, Sebastian, et al.
Publicado: (2018)

Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
por: Badakhshi, Harun, et al.
Publicado: (2018)

Clinical trials involving positron emission tomography and prostate cancer: an analysis of the ClinicalTrials.gov database
por: Cihoric, Nikola, et al.
Publicado: (2018)

Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy
por: Beck, Marcus, et al.
Publicado: (2017)

Regional hyperthermia of the abdomen, a pilot study towards the treatment of peritoneal carcinomatosis
por: Beck, Marcus, et al.
Publicado: (2015)

Radiofrequency applicator concepts for thermal magnetic resonance of brain tumors at 297 MHz (7.0 Tesla)
por: Oberacker, Eva, et al.
Publicado: (2020)

Role of Dose Intensification for Salvage Radiation Therapy after Radical Prostatectomy
por: Beck, Marcus, et al.
Publicado: (2016)

Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals
por: Wüstemann, Till, et al.
Publicado: (2016)

Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
por: Hemmati, Saman Moritz, et al.
Publicado: (2019)

Pulmonary toxicity generated from radiotherapeutic treatment of thoracic malignancies
por: Deng, Guodong, et al.
Publicado: (2017)

Radiotherapy for Non-Hodgkin’s lymphoma: still standard practice and not an outdated treatment option
por: Zimmermann, Michel, et al.
Publicado: (2016)

Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspectives
por: Seifert, Georg, et al.
Publicado: (2016)

Integrin Targeted Delivery of Radiotherapeutics
por: Liu, Zhaofei, et al.
Publicado: (2011)

Regulatory T Cells in Radiotherapeutic Responses
por: Schaue, Dörthe, et al.
Publicado: (2012)

Patient-Specific Planning for Thermal Magnetic Resonance of Glioblastoma Multiforme
por: Oberacker, Eva, et al.
Publicado: (2021)

External application of liver compresses to reduce fatigue in patients with metastatic cancer undergoing radiation therapy, a randomized clinical trial
por: Ghadjar, Pirus, et al.
Publicado: (2021)

Prevention of radiochemotherapy-induced toxicity with amifostine in patients with malignant orbital tumors involving the lacrimal gland: a pilot study
por: Goldblum, David, et al.
Publicado: (2008)

Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer
por: Kaul, David, et al.
Publicado: (2015)

PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives
por: Zschaeck, Sebastian, et al.
Publicado: (2018)

Radiotherapeutic alternatives for previously irradiated recurrent gliomas
por: Combs, Stephanie E, et al.
Publicado: (2007)

Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy
por: Lee, Sungmin, et al.
Publicado: (2018)

STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy
por: Yang, Ping-Lian, et al.
Publicado: (2020)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Risks and Benefits of Fiducial Marker Placement in Tumor Lesions for Robotic Radiosurgery: Technical Outcomes of 357 Implantations
por: Kord, Melina, et al.
Publicado: (2021)

Radiotherapeutic Strategies in the Management of Low-Risk Prostate Cancer
por: Choe, Kevin S., et al.
Publicado: (2010)

Impact of early radiological response evaluation on radiotherapeutic outcomes in the patients with nasal cavity and paranasal sinus malignancies
por: Hojo, Hidehiro, et al.
Publicado: (2012)

Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial
por: Müller, Arndt-Christian, et al.
Publicado: (2015)

Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation
por: Bodis, Stephan, et al.
Publicado: (2022)

To Optimize Radiotherapeutic Plans for Superior Tumor Coverage Predicts Malignant Glioma Prognosis and Normal Tissue Complication Probability
por: Kuo, Chun-Yuan, et al.
Publicado: (2022)

Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias.
por: Keeling, A. A., et al.
Publicado: (1989)

Clinical practice guideline on the optimal radiotherapeutic management of brain metastases
por: Tsao, May N, et al.
Publicado: (2005)

Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT)
por: Combs, Stephanie E, et al.
Publicado: (2006)

Müllerian duct anomalies and their effect on the radiotherapeutic management of cervical cancer
por: Rastogi, Madhup, et al.
Publicado: (2013)

Tailored radiotherapeutic strategies for disseminated uterine cervical cancer patients
por: Im, Jung Ho, et al.
Publicado: (2015)

Radiotherapeutic management of brain tumours during the COVID-19 pandemic
por: Balakrishnan, Rajesh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_02kmlvj90b24tl45vn6m0d2kpf